| III-14 giovanni Di Veroli Bone Remodeling QSP to Guide Clinical Trial Design of WNT pathway inhibitors Thursday 09:50-11:20 |
| III-20 Anubha Gupta Characterisation of time course of response using model based meta-analysis of public domain data to support trial design in axial spondyloarthritis Thursday 09:50-11:20 |
| III-21 Andrew Hooker Model-based adaptive optimal design for nonlinear mixed-effects models with model structure uncertainty. Application in a simulated dose-finding study. Thursday 09:50-11:20 |
| III-24 Alexander Janssen A Bayesian Optimization Procedure for the Automated Determination of Optimal Limited Sampling Strategies Thursday 09:50-11:20 |
| III-32 Romain Leroux Design evaluation and optimisation in nonlinear mixed effects models with the R package PFIM Thursday 09:50-11:20 |
| III-35 Claude Magnard Optimizing the sample size of a bridging study using Simulx, an application of the MonolixSuite Thursday 09:50-11:20 |
| III-43 Aziz Ouerdani Concentration-QTc analysis versus Intersection Union Test: sample size considerations for a thorough QT study Thursday 09:50-11:20 |
| III-45 Amr Radwan Design of a Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab in Children Aged 1-11 Years, With Active Eosinophilic Esophagitis Thursday 09:50-11:20 |
